Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01909713 · ClinicalTrials.gov registry record · Phase 4
Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.
A Phase 4 study, sponsored by Galderma R&D.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT01909713 is a Phase 4 study that has completed, run by Galderma R&D. The registered enrollment target is 35 participants.
The verdict
NCT01909713, a Phase 4 study, has completed, sponsored by Galderma R&D.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the tolerability of Cetaphil® DermaControl™ Foam Wash and Moisturizer SPF 30 in pediatric subjects (7-11) with acne prone skin.
Interventions
- DRUG Facial Cleanser and Moisturizer SPF 30
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2013-05 |
| Est. Completion | 2013-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01909713
The ClinicalTrials.gov registry entry for NCT01909713 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Galderma R&D, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Facial Cleanser and Moisturizer SPF 30 is the first listed.
NCT01909713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01909713 about?
NCT01909713 is a clinical study titled "Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin.". The purpose of this study is to determine the tolerability of Cetaphil® DermaControl™ Foam Wash and Moisturizer SPF 30 in pediatric subjects (7-11) with acne prone skin.
What is the current status of trial NCT01909713?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2013-05. Estimated completion is 2013-06.
What interventions are being tested in trial NCT01909713?
The interventions under investigation include: Facial Cleanser and Moisturizer SPF 30 (DRUG).
Who is sponsoring clinical trial NCT01909713?
This trial is sponsored by Galderma R&D, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.